Mutation overview page TP53 - p.Y220C ( Substitution - Missense)
This section shows a general overview of the selected mutation. It describes the source of the mutation i.e gene name/sample name/tissue name with unique ID, and also shows the …
Mutation overview page TP53 - p.Y234C ( Substitution - Missense)
This section shows a general overview of the selected mutation. It describes the source of the mutation i.e gene name/sample name/tissue name with unique ID, and also shows the …
Mutation overview page TP53_ENST00000359597 - p.Y220C
This section shows a general overview of the selected mutation. It describes the source of the mutation i.e gene name/sample name/tissue name with unique ID, and also shows the …
Mutation overview page PRKCG - p.G407= ( Substitution - coding …
This section shows a general overview of the selected mutation. It describes the source of the mutation i.e gene name/sample name/tissue name with unique ID, and also shows the …
tp53 Hallmarks of Cancer - Wellcome Sanger Institute
tp53 Hallmarks of Cancer. Explore the role of tp53 in cancer within the context of the hallmarks behaviours and functional descriptions. tp53 tumor protein p53.
COSMIC | Catalogue of Somatic Mutations in Cancer
COSMIC v100, released 21-MAY-24. COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the world's largest and most comprehensive resource for exploring the impact of somatic …
PTEN Hallmarks of Cancer - Wellcome Sanger Institute
lipid phosphatase, modulator of the PI3K/AKT pathway, catalyses dephosphorylation of phosphatidylinositol-3,4,5-trisphosphate, a key molecule involved in cell growth signalling, …
Cell lines Project - Home Page - Wellcome Sanger Institute
Cell Lines Project v101, released 19-NOV-24. COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the world's largest and most comprehensive resource for exploring the impact of …
About COSMIC - Wellcome Sanger Institute
The Cancer Mutation Census (CMC) project is an undertaking to classify coding mutations in COSMIC and identify variants driving different types of cancer. The CMC integrates all coding …
CDKN2A Hallmarks of Cancer - Wellcome Sanger Institute
CDKN2A locus encodes two distinct proteins, p16INK4a and p14ARF, both of which demonstrate tumour suppressor activity in genetically distinct anticancer pathways: the 'Rb pathway' for …